Ingestion of aflatoxin B1 (AFB1) represents a major risk factor in the aetiology of human hepatocellular carcinoma. In the rat, the harmful effects of AFB1 can be prevented by the administration of certain drugs which induce hepatic detoxification enzymes. We have previously shown that treatment of rats with the chemoprotector ethoxyquin (EQ) results in a marked increase in expression of the Alpha-class glutathione S-transferase (GST) Yc2 subunit which has high activity towards AFB1-8,9-epoxide [Hayes, Judah, McLellan, Kerr, Peacock and Neal (1991) Biochem. J. 279,[385][386][387][388][389][390][391][392][393][394][395][396][397][398]. To allow an assessment of whether the increased expression of GST Yc2 represents a general adaptive resistance mechanism to chemical stress, that is invoked by both chemoprotectors and carcinogens, we have examined the effects of EQ, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), phenobarbital (PB), AFB1, 3-methylcholanthrene (3-MC) and clofibrate on the AFB,-glutathione-conjugating activity and the GST subunit levels in rat liver. In addition, the effect of these drugs on the hepatic levels of an aldehyde reductase (AFB1-AR) that metabolizes the cytotoxic dialdehydic form of AFB1 has been studied as this enzyme also appears to be important in chemoprotection. Administration of the antioxidants EQ, BHA or BHT, as well as PB, led to a marked increase in levels of the GST Yc2 subunit in rat liver, and this increase coincided with a substantial rise in the GST activity towards AFB1-8,9-epoxide; neither AFB1, 3-MC nor clofibrate caused induction of Yc2 or any of the GST subunits examined. Among the xenobiotics studied, EQ was found to be the most effective inducing agent for the Yc2 subunit as well as Ycl, Yb1 and Yf. However, PB was equally as effective as EQ in increasing levels of the Ya-type subunits, although it was not found to be as potent an inducer of the other GST subunits, including Yc2. In addition to induction of GST, EQ caused a substantial increase in the hepatic content of AFB1-AR. Both BHA and BHT were also able to induce this enzyme but, by contrast, PB was found to be a poor inducer of AFB1-AR. AFB1, 3-MC and clofibrate were unable to serve as inducers of this reductase. The presence of Alpha-class GST, including the Yc2 subunit, was examined in various rat tissues. Constitutive expression of Yc2 was found in the epididymis at levels comparable with that observed in the liver from EQ-treated rats. Epididymal expression of Yc2 was accompanied by a high GSH-conjugating activity towards AFB1-8,9-epoxide which was not found in any other organ from normal rats. The highest levels of AFB1-AR were found in the kidney, followed by moderate levels in the liver and testis. Other extrahepatic organs such as heart, lung, spleen, adrenal gland, epididymis, vas deferens, seminal vesicles and ovary contain much lower levels of AFB1-AR.
INTRODUCTION
Aspergillus flavus, a mould widely encountered in tropical and subtropical areas as a contaminant of poorly stored grain crops, produces aflatoxin B1 (AFB1) as a secondary metabolite. AFB1 is a potent hepatotoxin and carcinogen, and, along with Hepatitis B virus, is suspected to represent a major factor contributing to the high incidence of liver cancer in man in the developing world (for a review, see Groopman et al., 1988) .
Hepatic metabolism of ingested AFB1 is extensive. Much of its toxicity can be attributed to the metabolite, AFB1-8,9-epoxide, the formation of which is catalysed by the microsomal monooxygenase system (Neal, 1987) . The AFB,-epoxide is a highly reactive electrophile and reacts readily with cellular macromolecules. There are, however, endogenous defence mechanisms which can protect cells from the toxicity of AFB,-epoxide, including conjugation reactions, active efflux from the cell and repair of AFB1 DNA adducts (Hayes et al., 1991a) . In many mammalian cells, detoxification of AFB1-epoxide by phase-Il drug metabolism is of principal importance. Activated AFB1 can be conjugated with glutathione, a reaction catalysed by the glutathione S-transferases (GSTs), and this step is thought to represent a major detoxification mechanism. Alternatively, the AFB1-epoxide can hydrolyse spontaneously to AFB1-dihydrodiol. This is not a true detoxification process as the dihydrodiol product can rearrange at neutral pH values to form a dialdehydic phenolate ion. This AFB1-dialdehyde can undergo Schiff-base formation with primary amine groups in proteins and is therefore likely to be cytotoxic. Recently, a novel AFB1-aldehyde reductase (AFB1-AR) purified from ethoxyquin (EQ)-treated rat liver has been shown to metabolize the dialdehyde form of AFB1-dihydrodiol to an AFB1-dialcohol and its relative importance in AFB1 detoxification may be considerable Judah et al., 1993a) .
The toxicity of AFB1 is selective towards certain species. In contrast with the mouse and hamster, the rat, guinea pig and man are susceptible to the hepatotoxic effects of AFB1 (O'Brien et al., 1983; Hayes et al., 1991a) . The toxicity of the mycotoxin is based on a balance between the rate of primary activation of AFB1 and the rate of detoxification of primary metabolites or Abbreviations used: AFB1, aflatoxin B1; GST, glutathione S-transferase; EQ, ethoxyquin; BHA, butylated hydroxyanisole; BHT, butylated hydroxytoluene; PB, phenobarbital; 3-MC, 3-methylcholanthrene; AFB-AR, AFB,-aldehyde reductase; CDNB, 1-chloro-2,4-dinitrobenzene; DCNB, 1,2-dichloro-4-nitrobenzene; tPBO, trans-4-phenylbut-3-en-2-one.
I Present address: Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, U.K. § To whom correspondence should be addressed.
repair of cellular damage, determined by the relative activity of enzymes responsible for these reactions; the differential toxicity of AFB, between species is thought to be due mainly to different levels of activity of xenobiotic-metabolizing enzymes. In this regard, the livers of mice which are resistant to the hepatoxic effects of AFB1 contain high concentrations of a Yc-type GST subunit (McLellan et al., 1991) that has considerable GSHconjugating activity towards AFB1-epoxide (Quinn et al., 1990; Ramsdell and Eaton, 1990; Hayes et al., 1991a Hayes et al., , 1992 . By contrast, the Fischer rat, an inbred strain that is five times more susceptible to AFB1-induced liver cancer than the Wistar rat (Hayes et al., 1991a) , possesses 20-fold less hepatic AFB1-GSH-conjugating activity than the mouse. Fischer rats can, however, be protected against AFB1 by treatment with the antioxidant EQ. We have shown that following EQ-treatment the livers of Fischer rats express a GST subunit that is immunochemically related to the mouse Yc subunit (Hayes et al., 1991b) . Moreover, this inducible polypeptide (Yc2, subunit 10) has high activity towards AFB1-epoxide (Hayes et al., 1991b; Raney et al., 1992) . Thus, the Yc2 subunit is thought to confer protection against AFB1, and its induction by EQ is likely to be one of the key mechanisms for the protective action of this anti-carcinogen.
Chemoprotectors are a group of structurally diverse compounds that have the ability to protect animals from the toxic effects of carcinogenic xenobiotics (Wattenberg, 1985) . Many of these anti-carcinogens are thought to act by increasing levels of hepatic drug-metabolizing enzymes, thus enhancing detoxification and elimination of chemical carcinogens (Prochaska and Talalay, 1988; Talalay, 1989) . EQ, butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) are all antioxidants that have been described as having anti-carcinogenic properties (Ito et al., 1985) . Furthermore, all of these compounds have been shown to protect rats from AFB1-mediated hepatocarcinogenesis.
In addition to antioxidants, both phenobarbital (PB) and 3-methylcholanthrene (3-MC) have been shown to be capable of protecting rodents from carcinogens (Miller et al., 1958; Lotlikar et al., 1989 ). Also, low-level feeding of AFB1 to rats before injection of a higher dose has been shown to reduce the incidence of covalent binding of AFB1 to DNA (Neal et al., 1981) . It is, however, unknown whether these compounds with chemoprotective properties act in a similar manner to EQ by inducing enzymes able to detoxify AFB1 metabolites. The control of enzyme activities responsible for the detoxication of AFB1 is of particular interest, because ofits relevance to human liver disease. In the present study we have examined the effects of several chemoprotectors on hepatic levels of enzymes capable of detoxifying AFB1-expoxide: specifically, GST Yc2 and AFB1-AR. In addition, we have investigated the tissue distribution of GST Yc2 and AFB1-AR in Fischer rats to establish whether their constitutive expression is co-ordinated.
MATERIALS AND METHODS Chemicals Androst-5-ene-3,17-dione was a gift from Dr. P. K. Stockman (Royal Infirmary, Edinburgh, U.K.). All other chemicals were of analytical grade and readily available commercially.
Animals
Adult male Fischer 344 rats (300-450 g), bred and maintained at the Imperial Cancer Research Fund Animal Unit, Clare Hall, London, were used to examine the effects of xenobiotics on levels of hepatic drug-metabolizing enzymes. Each group of rats (four animals per group) were fed the same basic powdered diet (standard laboratory diet) to which the following compounds were added: (1) no additives, (2) peanut oil (2%, v/w), (3) EQ (0.5 %, w/w) dissolved in peanut oil at a final concentration of 2 % (v/w) in the diet, (4) BHA (0.75 %, w/w), or (5) BHT (0.5 %, w/w). An additional group of rats were given (6) phenobarbital (PB) (0.1 0%, w/v) in their drinking water with no additives to the food. Dietary additives were administered for 14 days before the animals were killed. Alternatively, the rats were injected intraperitoneally with the following: (7) corn oil only (0.5 ml/day for 4 days), (8) AFB1 (0.2 mg/kg) in corn oil (0.5 ml/day for 4 days), (9) clofibrate acid (200 mg/kg) in corn oil (0.5 ml/day for 4 days), or (10) 3-MC (100 mg/kg) in corn oil (0.5 ml/day for 3 days). Fischer 344 rats (150-200 g; Bantin and Kingman, Hull, U.K.) were used to examine the tissue distribution of AFB1-epoxide-metabolizing enzymes. Adult males (four animals) were used for the excision of all tissues except for ovarian samples where four adult females were used. In all instances, the rats were allowed free access to food and water until killed.
Subcellular fractionation
The organs used for subcellular fractionation were stored at -80°C until required. Cytosols and microsomes were prepared by a similar method to that described by McLellan et al. (1991) .
Analytical methods
Enzyme assays for GST activity towards the model substrates and glutathione peroxidase activity were carried out at 37°C as described previously (McLellan and Hayes, 1989; McLellan et al., 1991) . GST activity towards AFB1-epoxide was measured as described by Hayes et al. (1991b) . The AFB1-AR activity was measured by the method of Judah et al. (1993) . Protein determination was by the method of Bradford (1976) adapted for use on a Cobas Fara centrifugal analyser (Roche Diagnostics, Welwyn Garden City, Herts., U.K.). Antisera Polyclonal antisera raised against rat hepatic GST [Alpha-class (Ya1Ya2, Yc1Yc1 and YkYk), Mu-class (YblYbl), Pi-class (YfYf) and microsomal GST] were used in immunoblotting experiments as described in previous publications (Hayes and Mantle, 1986a,b; McLellan and Hayes, 1989) . Antibodies that crossreacted specifically with the rat Yc2 subunit, without crossreactivity with Ycl, were prepared from polyclonal antisera raised against the mouse Yc subunit [a constitutive hepatic subunit with high amino-acid-sequence similarity to rat Yc2 and previously designated Ya3 (McLellan et al., 1991; Hayes et al., 1992) ] as described elsewhere (Judah et al., 1994 by filtration on a scintered-glass funnel and discarded. The mouse YcYc-Sepharose was retained and washed with approx. 50 ml of 20 mM Tris/HCl, pH 7.5, containing 0.5 M NaCl and 0.05 % (v/v) Tween 20, followed by approx. 50 ml of 20 mM sodium phosphate buffer, pH 7.2, containing 0.25 M NaCl. The gel was eluted with 0.1 M glycine buffer, pH 2.5, and the eluate immediately titrated to approx. pH 7.5 with 1 M Tris solution.
The eluate was dialysed against two changes of 2 litres of 20 mM Tris/HCl, pH 7.5, containing 0.5 M NaCl. Finally, the semipurified IgG was incubated overnight with rat YalYc1-Sepharose (prepared with GST YalYcl purified from rat liver and CNBractivated Sepharose as described above) in the presence of Tween 20 (0.05 %, v/v). The mixture was filtered on a sintered-glass funnel and the eluate retained as the affinity-purified antibody specific for the rat Yc2 subunit.
Electrophoresis and immunoblotting
The methods described previously by Hayes and Mantle (1986a,b) were used. The immunoblots were quantified by visual estimation.
RESULTS
Effect of chemoprotective xenoblotics on hepatic GST activity In rats Several xenobiotic compounds, of which many have been reported to increase GST activity towards model substrates in rodents, were tested for their ability to modulate GST activity towards AFB1-8,9-epoxide (Table 1) . Of these, the antioxidants BHA, BHT and EQ, as well as PB, were found to increase activity towards AFB1-epoxide between 3-and 5-fold, with EQ being the most effective inducing agent. Neither AFB1, 3-MC nor clofibrate had any effect on AFB1-epoxide-conjugating activity. When the 'general' substrate, l-chloro-2,4-dinitrobenzene (CDNB) was employed in enzyme assays, EQ, BHA, BHT and PB were all found to increase GST activity by approx. 2.5-fold.
The compounds AFB1 and 3-MC had little effect on GST activity towards CDNB. By contrast, clofibrate-treatment was found to cause a decrease in the specific activity towards CDNB.
Of the other GST substrates tested [androst-5-ene-3,17-dione, trans-4-phenylbut-3-en-2-one (tPBO), 1,2-dichloro-4-nitrobenzene (DCNB) and ethacrynic acid], EQ, BHA, BHT and PB were all found to be effective inducers of activity. Neither AFB1 nor 3-MC proved to be good inducers of GST activity for any of the substrates tested. Clofibrate did not increase GST activity for any of the substrates, and for all the activities examined, except that of glutathione peroxidase, cytosol from clofibrate-treated animals had a lower specific activity than control cytosol. None of the compounds tested was effective in inducing glutathione peroxidase activity towards either cumene hydroperoxide or H202 Furthermore, as reported previously by Hayes et al. (1991b) , EQ was found to cause a reduction in glutathione peroxidase activity that was most pronounced when H202 was employed as a substrate. BHT, BHA and PB were found to cause modest reductions in this activity. This was also true of 3-MC. However, neither AFB1 nor clofibrate caused any obvious changes in glutathione peroxidase activity.
Induction of AFB1-epoxide-metabolizing enzymes by compounds that protect against AFB, hepatotoxicity In order to determine which GST isoenzymes were responsible for the increases in activity seen in the cytosol obtained from xenobiotic-treated rats, levels of individual subunits were examined by Western-blotting analysis (Figure la). Of particular interest is the hepatic content of the Yc2 subunit, which has been shown to have a high specific activity towards AFB1-epoxide and is known to increase following administration of EQ (Hayes et al., 199 lb) . However, the regulation of the Yc2 subunit by BHA, BHT, PB, 3-MC, clofibrate or AFB1 has not been studied previously. To examine levels of this subunit specifically we purified an antibody that would only react with the rat Yc2 subunit from antisera raised to mouse YcYc (see the Materials and methods section). This strategy circumvented the problem of cross-reactivity with the other rat Alpha-class subunits, Ycl and Ya.
Of all the hepatic GST subunits examined, the most pronounced antioxidant-mediated induction was that of the Yc2 subunit, which was induced by between 10-and 15-fold by EQ treatment. BHA, BHT and PB were also effective inducing agents for the Yc2 subunit, although to a slightly lesser extent than EQ. Neither AFB1, 3-MC nor clofibrate caused elevated levels of the Yc2 subunit. This result is compatible with the rises in GST activity towards AFB1-epoxide seen after treatment with Levels of both Mu-(Ybl) and Pi-(Yf) class GST subunits in the liver cytosols from treated animals were examined. The concentration of the Pi-class Yf subunit was found to be increased by both EQ and BHA (2-3-fold), but not by BHT or PB. As with all the other GST subunits examined, Yf was not induced after treatment with AFB1, 3-MC or clofibrate. The Mu-class Yb1 subunit concentration was elevated by approx. 4-fold and 3-fold following treatment with EQ and PB respectively. Both BHA and BHT caused a more modest increase (1.5-2-fold) in the level of the Yb1 subunit, and concentrations of this subunit did not appear to be affected by AFB1, 3-MC or clofibrate. The presence of the microsomal GST was also examined, but none of the compounds tested caused any detectable changes in level of this enzyme.
Contrary with the findings presented here, earlier studies have reported that 3-MC causes an increase in GST activity in rat liver, as well as transcriptional activation of GST genes (Igarashi et al., 1987; Ding and Pickett, 1985) . Thus, it was critical to establish whether the lack of GST induction found in the present study was accompanied by induction of members of the cytochrome P-450 IA family; CYP450 IA genes are transcriptionally activated by 3-MC via the Ah receptor and xenobiotic response elements (XRE), and failure to induce CYP450 IA proteins would indicate that this mechanism of induction was not active under the experimental conditions used. Figure l(b) shows the Western blot obtained when the rat liver microsomal fractions were probed with antisera raised against CYP450 1A2 protein. It is clear that members of the CYP450 IA family have been induced by greater than 30-fold in response to 3-MC. It is interesting to note that EQ can also induce IA cytochrome P-450(s).
In addition to GSTs, a recently described aldehyde reductase (AFB1-AR) is thought to play a pivotal role in EQ-mediated chemoprotection against activated metabolites of AFB1 Ellis et al., 1993) . It was important to determine whether other chemoprotectors besides EQ would cause induction of AFB1-AR. The cytosols from the xenobiotic-treated rats were examined by Western blotting (Figure lc ) using antisera raised against purified AFB1-AR. Although EQ was found to be the most effective inducing agent for this enzyme, causing an approx. 10-15-fold induction, BHA, BHT and PB also caused induction. BHA caused a 5-8-fold elevation in levels of AFB1-AR and BHT a 3-4-fold increase. PB was the poorest of the dietary inducing agents, causing only a 2-fold increase in the reductase. Neither AFB1, 3-MC or clofibrate was an effective inducing agent for AFB1-AR.
Tissue distribution of AFB1-detoxifying enzymes In untreated adult Fischer 344 rats, the Yc2 subunit is normally undetectable in the liver. It was of interest to determine whether the enzyme is expressed constitutively at high levels in rat organs other than the liver; this could perhaps be indicative of a potential endogenous function for Yc2-containing enzymes.
Levels of GST activity towards AFB1-epoxide in several extrahepatic organs from untreated Fischer 344 rats were determined (Table 2) . Of all the organs examined (liver, kidney, heart, lung, spleen, adrenal gland, testis, epididymis, vas deferens, seminal vesicles and ovary), only the epididymis was found to exhibit high constitutive specific activity towards AFB1-epoxide. The level of activity in this organ was shown to be 15 times higher than that found in untreated liver and 20-60 times higher than that in any of the other organs studied. The epididymis was also found to have a high specific activity towards CDNB, DCNB and tPBO, indicating high levels of Mu-class subunits. Ethacrynic acid also served as a good substrate for epididymal GST, but the specific activity towards androst-5-ene-3,17-dione, a substrate for which Ya-type subunits have a high specific activity, was low. In the epididymis, glutathione peroxidase activity towards cumene hydroperoxide was approx. twice as high as that towards H202' This indicates that a substantial portion of the activity is being contributed by a selenium-independent glutathione peroxidase, such as a GST, that cannot utilize H202 as substrate. Of the other organs examined, only the liver and kidney contained appreciable levels of activity towards androst-5-ene-3,17-dione, with the liver containing around seven times as much activity as the kidney. The liver also contained the highest level of glutathione peroxidase activity. As has been reported previously, the testis has a high specific activity towards CDNB, DCNB and tPBO, probably attributable to the presence of the Yn1 subunit and Yb2 (Hayes, 1984; Hayes and Mantle, 1986a) . By contrast, the ovary contained a much lower level of activity towards those substrates.
In an attempt to establish which GST is responsible for the high specific activity towards AFB1-epoxide in the epididymis, the extrahepatic organ cytosols were examined by Western blotting, using antisera raised against the Alpha-class GSTs: members of the Alpha class of GSTs are thought most likely to be responsible for GST activity towards AFB1-epoxide (Hayes et al., 1991a) . Figure 2 clearly demonstrates that the epididymis is the only organ that expresses the Yc2 subunit constitutively. The Yc1 subunit was found to be expressed in all organs examined, with only the heart containing very low levels. It is notable that the kidney appeared to contain two bands with similar mobility that strongly cross-reacted with the antibody raised to Ycl.
Neither of these polypeptides cross-reacted with the affinitypurified antibody specific for Yc2-type subunits. When antisera raised to Ya subunits were used to probe the extrahepatic organs, the liver was found to express the highest levels of this subunit, with the kidney containing lesser but substantial quantities. The 
DISCUSSION
It has been known for more than 35 years that chemically mediated carcinogenesis can be inhibited by administering compounds such as polycyclic aromatic hydrocarbons at low doses to rats (Miller et al., 1958) . The potential of xenobiotic compounds to protect animals from chemical carcinogenesis has since been further explored and developed, and a plethora of chemoprotectors (or anti-carcinogens) identified [see Wattenberg (1985) for a review]. The means by which chemoprotectors reduce the incidence of chemical carcinogenesis is diverse and multifactorial, but it is likely that the principal mechanism of action of many of these chemicals is to alter levels of xenobiotic-metabolizing enzymes, thus increasing the capacity for carcinogen detoxification and excretion.
AFB1 is a naturally occurring carcinogen and, as with many synthetic chemical carcinogens, its carcinogenic potency can be modulated in rats by the administration of chemoprotective agents [for a review, see Hayes et al. (199la) ]. It has been demonstrated previously in our laboratories that the chemoprotector, EQ, causes elevations in the level of a GST subunit, Yc2, that has high specific activity towards AFB,-8,9-epoxide (Hayes et al., 199 lb) . An aldehyde reductase (AFB1-AR) capable of detoxifying a dialdehydic product of AFB1 metabolism has also been identified as an EQ-inducible protein . The hepatic induction of both of these two cytosolic proteins is likely to make a major contribution to the anticarcinogenic mechanism of EQ, although it should also be noted that EQ modestly enhances the ability of liver microsomes to detoxify AFB1 to aflatoxins Q1 and M1 (Mandel et al., 1987) . It was previously unknown if other compounds with chemoprotective properties acted in a similar way to EQ by inducing AFB1-detoxifying enzymes, in particular, the GST subunit Yc2 and AFB1-AR.
Control of AFB1-detoxifying enzymes by antioxidants and PB
Of all the compounds studied, EQ was found to be the most effective inducer of GST activity towards AFB1-8,9-epoxide, although not necessarily towards all of the other substrates examined. The rise in specific activity towards AFB,-epoxide coincided with a substantial increase in the level of the Yc2 subunit, which was induced by between 10-and 15-fold by EQ. It should be noted, however, that the 10-15-fold increase in concentration of the Yc2 subunit was accompanied by only a 5-fold increase in specific activity towards AFB1-epoxide. This result suggests that constitutively expressed GSTs are responsible for the basal level of AFB1-epoxide-conjugating activity. Indeed, we have shown previously that Yc1-containing GSTs possess a very modest specific activity towards AFB,-epoxide (Hayes et al., 1991b) , and as the Ycl subunit is abundant in untreated rat liver it is likely that it contributes to the basal specific activity towards AFB1-epoxide.
The Yc2 subunit appears to be induced by a variety of drugs.
In the present study we have shown that the Yc2 subunit is induced in rat liver after treatment with each of the phenolic antioxidants, BHA, BHT and EQ, as well as by PB. Recently, Meyer et al. (1993) have demonstrated that Yc2 expression is markedly increased after administration of 1,2-dithiole-3-thiones, compounds which also possess antioxidant properties. It is apparent therefore, that as a group, the synthetic antioxidants are ofmajor importance in regulating genes that protect against also occur naturally in cruciferous vegetables [for a review see Wattenberg (1992) ], leading to the possibility that natural antioxidants in the diet can significantly alter susceptibility to AFB1 carcinogenesis through modulation of hepatic levels of GST Yc2.
The three antioxidants tested here, and PB, all increase the hepatic levels of Ya-type subunits, with EQ and PB having the greatest effect. Both of these inducing agents caused an approx. 3-fold induction of Ya subunits, whereas BHA and BHT caused a 2-fold induction. Although GST Ya subunits have little catalytic activity towards AFB1-8,9-epoxide (Hayes et al., 1991b) , the increase in this subunit type may help protect against AFB1 through the ability of Ya-containing GST to sequester the mycotoxin, thereby preventing it from interacting with DNA. The Ya-containing GSTs have been shown to be capable of covalently binding carcinogens such as 3-MC (Ketterer, 1972) , and it should be noted that following exposure of chicken embryo primary hepatocytes to AFB1, Iwaki et al. (1990) found that the mycotoxin specifically associated with a polypeptide of Mr 25000. Although not identified as a GST subunit, this polypeptide, which binds AFB1 covalently, is closely similar in size to the Ya subunits.
Induction of the Yc1-type subunits was much less marked than either Ya or Yc2, with EQ causing the greatest effect (1.5-2-fold). The Yk subunit did not appear to be induced by any of the compounds examined. Hayes et al. (1991b) reported an approx. 2-fold increase in Yk after treatment of rats with EQ. This discrepancy could be simply due to differences in methodology for detection of the Yk subunit, but it is possible that the difference in the age of rats (10-15 weeks cf. 8-12 months) had an effect as it has been shown by McCusker et al. (1989) (Pearson et al., 1983; Sato et al., 1984; Hayes et al., 1991c) , and that, in rat, PB can cause transcriptional activation of the gene encoding Ybl (Pickett et al., 1987) . The mouse Yb1 gene has been studied in relation to its induction by BHA (Reinhart and Pearson, 1993) . It is believed that BHA can be metabolized in vivo to the reactive quinone, t-butylhydroquinone (Branen, 1975) Pickett, 1990; Rushmore et al., 1991) . However, Reinhart and Pearson (1993) When levels of AFB1-AR were measured in rat liver cytosol it was found that EQ was the most effective inducing agent, causing between 10-and 15-fold induction. BHA and BHT were also effective in inducing AFB1-AR, producing a 6-8-fold and 3-4-fold induction respectively. PB caused only a 2-fold induction of AFB1-AR. AFB1-AR was identified only recently as an EQinducible protein capable of reducing a potentially toxic dialdehydic product of AFB1 metabolism Judah et al., 1993) and little is known about the control of its activity. It has been demonstrated that induction of the AFB1-AR protein by EQ is accompanied by an increase in the level of mRNA (Ellis et al., 1993) , although the mechanism by which this happens is still unclear.
The effect of 3-MC on AFB1-metabolizing enzymes The Yc2 subunit was not found to be induced by 3-MC, a compound that has been described as a chemoprotective agent (Miller et al., 1958) . However, 3-MC has been reported previously to increase hepatic GST activity in rats, which is in contrast with the results reported in the present study (Ding and Pickett, 1985; Igarashi et al., 1987) . Igarashi et al. (1987) demonstrated that 3-MC caused a rise in GST activity and of the concentration of Ya subunits in rat liver. Ding and Pickett (1985) also showed transcriptional activation of Alpha-and Mu-class GST genes in rat liver after 3-MC treatment. The work described herein shows little, if any, increase in GST activity towards any of the substrates tested after 3-MC treatment, and levels of the GST subunits, as determined by Western-blot analysis, appeared to undergo little change. It does not seem likely that these conflicting data can simply be explained by differences in drug regimens between laboratories, as the dose of 3-MC used in this study was two and five times greater respectively than those described by Ding and Pickett (1985) and Igarashi et al. (1987) . The only major difference in experimental design is that of age, size and strain of rats. The rats used in the laboratories of both Ding and Pickett (1985) and Igarashi et al. (1987) were young adult male Sprague-Dawley rats, being 150-200 g and 3-7 weeks old in the respective laboratories. By contrast, we used Fischer 344 rats of approx. 400 g (8-12 months old) for our induction study. Like the Yk subunit, Ya is developmentally regulated and basal expression increases with age (McCusker et al., 1989 At present, the nature of the inducing signal for increased GST Yc2 expression is unknown. However, Rushmore et al. (1991) have shown that the antioxidant response element on the rat Ya subunit is responsive to H202 and reactive-oxygen species in transfected human hepatoma cells. It was thus of interest to determine whether drugs that can generate oxidative stress in vivo could induce the Yc2 and Ya subunits. Clofibrate is a hepatocarcinogen that has been shown to increase the number of peroxisomes in hepatic parenchymal cells (Rao and Reddy, 1987 Tissue-specific regulation of enzymes capable of detoxifying AFB1 metabolites Among the extrahepatic organs studied (kidney, heart, lung, spleen, adrenal gland, testis, epididymis, vas deferens, seminal vesicles and ovary), the only one found to contain detectable quantities of the Yc2 subunit was the epididymis. The concentration of Yc2 in the epididymis is probably comparable with that seen in EQ-treated rat liver. Furthermore, the level of AFB1-8,9-epoxide-conjugating activity compared favourably with that of EQ-treated rat liver, with specific activities of 0.194 nmol/min per mg of protein and 0.199 nmol/min per mg of protein found in EQ-treated rat liver and epididymis respectively. The presence of Yc2 in the epididymis is intriguing and does imply a role for Yc2 that is separate from AFB1-epoxide metabolism. Although it is feasible that its function in the epididymis is solely to conjugate GSH with xenobiotics that can enter the seminal fluid, the Yc2 subunit has relatively high glutathione peroxidase activity (Hayes et al., 1991b) and it is possible that the role of Yc2 in the epididymis is that of a glutathione peroxidase. The epididymis is the site of sperm maturation and storage, and as spermatozoa are very sensitive to lipid peroxidation (with loss of motility and fertility being the consequence), it is important that this organ contains enzymes that can combat oxidative stress. In some mammals, glutathione peroxidase(s) is thought to be a major factor in preventing the loss of sperm fertility associated with oxidative damage (Mann and Lutwak-Mann, 1981) . A novel glutathione peroxidase has recently been isolated from rat epididymis (Perry et al., 1992) and like the Yc2 subunit it appears to be specific to this organ. The epididymal glutathione peroxidase was found to be regulated by androgens, although its possible regulation by androgens in organs other than the epididymis was not determined. It is possible that Yc2 is regulated in a similar manner; Robaire and Hales (1982) 
Concluding comments
Both of the phase-II detoxification enzymes that appear to be most influential in protecting against the activated metabolites of AFB1 (i.e. GST Yc2 and AFB1-AR) are present in low concentrations in normal adult male rat liver. In the present study we have shown that the Yc2 subunit seems, in many instances, to be regulated in a co-ordinate manner to AFB1-AR. Both enzymes are induced by feeding rats with the antioxidants BHA, BHT and EQ. Moreover, both enzymes are present in high concentrations in hepatic tumours derived from AFB1-fed rats .There are, however, also some notable differences in the regulation of Yc2 and AFB1-AR. Hayes et al. (1993) demonstrated that developmental regulation of the two proteins is distinct, in that fetal rat liver contains high concentrations of Yc2 but very little AFB1-AR. The present study demonstrates that tissue-specific regulation is a further example where regulation of Yc2 and AFB1-AR differs. Unlike AFB1-AR, high levels of Yc2 are present in the epididymis. Substantial quantities of AFB1-AR were also found to be present in the kidney, whereas Yc2 was undetectable. It has yet to be determined whether the mechanisms governing drug induction of these AFB1-detoxifying enzymes are similar for both Yc2 and AFB1-AR. This is currently being examined in our laboratories.
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